Edition:
United Kingdom

Anika Therapeutics Inc (ANIK.OQ)

ANIK.OQ on NASDAQ Stock Exchange Global Select Market

53.44USD
15 Dec 2017
Change (% chg)

$0.67 (+1.27%)
Prev Close
$52.77
Open
$52.71
Day's High
$53.66
Day's Low
$52.58
Volume
75,076
Avg. Vol
31,674
52-wk High
$60.28
52-wk Low
$41.64

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.46 December 16 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 2 30.22 30.38 30.07 32.57
Quarter Ending Mar-18 2 25.06 25.30 24.81 --
Year Ending Dec-17 2 114.25 114.41 114.10 115.80
Year Ending Dec-18 2 119.14 122.60 115.68 123.06
Earnings (per share)
Quarter Ending Dec-17 2 0.46 0.47 0.45 0.61
Quarter Ending Mar-18 2 0.31 0.34 0.29 --
Year Ending Dec-17 2 2.04 2.05 2.02 2.14
Year Ending Dec-18 2 1.83 2.01 1.65 2.15
LT Growth Rate (%) 1 10.00 10.00 10.00 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 27.56 27.18 0.38 1.37
Quarter Ending Jun-17 27.20 33.46 6.27 23.04
Quarter Ending Mar-17 23.89 23.39 0.50 2.11
Quarter Ending Dec-16 27.84 28.73 0.89 3.19
Quarter Ending Sep-16 26.59 25.79 0.81 3.03

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 30.22 30.22 30.22 31.44 32.57
Quarter Ending Mar-18 25.06 25.06 25.06 25.91 --
Year Ending Dec-17 114.25 114.25 114.25 119.70 115.80
Year Ending Dec-18 119.14 119.14 119.14 124.09 123.06

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings